Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Sep 13;178:113971. doi: 10.1016/j.addr.2021.113971

Fig.3.

Fig.3.

TGMS assembly and release of TA. (A) Schematic illustrating fabrication and application of TGMS in inflammation. (B) Effect of matrix mellatoproteinase 9 (MMP-9) on cumulative release of TA. (C) Effect of synovial fluid from arthritic joints (SF-RA) on cumulative release of TA. Data in Figures 3B and 3C reprinted from N. Joshi, J. Yan, S. Levy, S. Bhagchandani, K.V. Slaughter, N.E. Sherman, J. Amirault, Y. Wang, L. Riegel, X. He, T.S. Rui, M. Valic, P.K. Vemula, O.R. Miranda, O. Levy, E.M. Gravallese, A.O. Aliprantis, J. Ermann, J.M. Karp, Towards an arthritis flare-responsive drug delivery system, Nat Commun. 9 (2018) 1275. https://doi.org/10.1038/s41467-018-03691-1. Creative Commons license https://creativecommons.org/licenses/by/4.0/. No changes were made to the material.